-transparent.png){kind=logo}
A single ipl injection of 0.25 mg CP into CBA mice led to accumulation of macrophages in the pleural cavity, but it did not influence RES as an injection given iv ipl CP caused a three-to-five-fold increase in the number of nucleated cells in the pleural cavity which persisted at least 14 days. Of these cells 86% were macrophages as shown by their esterase activity. Less than 30% of cells from the pleural cavity of normal mice were esterase positive. Macrophages from the pleural cavity of CP-treated mice were capable of destroying in vitro cultures of a syngeneic mammary carcinoma, while normal pleural macrophages exerted no effect; the former were not cytotoxic for either syngeneic or allogeneic embryo fibroblasts. Ipl CP protected mice against iv injected mammary carcinoma cells; given to mice 7 days after iv inoculation of tumor cells it significantly reduced the number of tumor nodules in their lungs.
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
January 1983,
Thorax,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
January 1995,
Respiration; international review of thoracic diseases,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
August 1987,
British journal of hospital medicine,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
July 1994,
Zhonghua hu li za zhi = Chinese journal of nursing,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
May 1985,
Pneumonologia polska,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
November 1980,
Thorax,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
January 1985,
European journal of respiratory diseases,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
January 1979,
Acta medica Austriaca,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
June 1980,
La Nouvelle presse medicale,
I Basić, and
B Rodé, and
A Kastelan, and
L Milas
January 1991,
Revue de pneumologie clinique,
